The Parkinson's disease drug entacapone disrupts gut microbiome homoeostasis via iron sequestration/Experiment 1/Signature 2

From BugSigDB
Needs review

Curated date: 2024/11/21

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Supplementary Table 5

Description: Differential abundance of taxa between the drug-amendment experiments(ENT-High, ENT-Low, LOX-High and LOX-Low) after 24hrs of incubation.

Abundance in Group 1: decreased abundance in Entacapone High Concentration(ENT-High) after 24 hrs of incubation

NCBI Quality ControlLinks
Agathobacter
Alistipes
Anaerostipes
Collinsella
Coprococcus
Fusicatenibacter
Methanobrevibacter
Parabacteroides
Senegalimassilia
Sutterella
[Ruminococcus] torques
candidate division VadinBE97
unclassified Candidatus Gastranaerophilales
unclassified Lachnospiraceae
uncultured Lachnospiraceae bacterium
Oscillospiraceae UCG-003Oscillospiraceae UCG-003
Prevotella_9Prevotella_9
Thomasclavelia
Erysipelotrichaceae UCG-003Erysipelotrichaceae UCG-003
Bacteroides
Bifidobacterium
Eggerthella
Clostridium
Blautia
Coprobacter
Candidatus Stoquefichus
Faecalibacterium
GCA-900066575GCA-900066575
Gordonibacter
unclassified Muribaculaceae
Christensenellaceae R-7 groupChristensenellaceae R-7 group
unclassified Clostridia vadinBB60 groupunclassified Clostridia vadinBB60 group

Revision editor(s): KateRasheed